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Abstract
Background: The i-gel has a gel-like cuff composed of thermoplastic elastomer that does not require cuff inﬂation. As the
elimination of cuff inﬂation may shorten insertion time, the i-gel might be a useful tool in emergency situations requiring prompt airway
care. This systematic review and meta-analysis of previous adult manikin studies for inexperienced personnel was performed to
compare the i-gel with other supraglottic airways.
Methods:We searched PubMed, the Cochrane Library, and EMBASE for eligible randomized controlled trials (RCTs) published
before June 2015, including with a crossover design, using the following search terms: “i-gel,” “igel,” “simulation,” “manikin,”
“manikins,” “mannequin,” and “mannequins.” The primary outcomes of this review were device insertion time and the ﬁrst-attempt
success rate of insertion.
Results: A total of 14 RCTs were included. At the initial assessment without difﬁcult circumstances, the i-gel had a signiﬁcantly
shorter insertion time than the LMA Classic, LMA Fastrach, LMA Proseal, LMA Unique, laryngeal tube, Combitube, and EasyTube.
However, a faster insertion time of the i-gel was not observed in comparisons with the LMA Supreme, aura-i, and air-Q. In addition,
the i-gel did not show the better results for the insertion success rate when compared to other devices.
Conclusion: The ﬁndings of this meta-analysis indicated that inexperienced volunteers placed the i-gel more rapidly than other
supraglottic airways with the exception of the LMA Supreme, aura-i, and air-Q in manikin studies. However, the quicker insertion time
is clinically not relevant. The unapparent advantage regarding the insertion success rate and the inherent limitations of the simulation
setting indicated that additional evidence is necessary to conﬁrm these advantages of the i-gel in an emergency setting.
Abbreviations: CIs = conﬁdence intervals, CPR = cardiopulmonary resuscitation, D–L = DerSimonian–Laird, ETI = endotracheal
intubation, MD = mean difference, M–H = Mantel–Haenszel, RCTs = randomized controlled trials, RR = relative risk.
Keywords: adult, airway management, laryngeal masks, manikins
1. Introduction ing elevation of intracranial pressure and unrecognized esoph-In emergency situations such as sudden cardiac arrest and apnea,
securing the airway for ventilation and oxygenation is a critical
life-saving procedure.[1] In this regard, endotracheal intubation
(ETI; Mallinckrodt, Athlone, Ireland) has been deemed as the
optimal method for ensuring a safe and patent airway. However,
ETI requires highly skilled operators and may result in prolonged
interruptions of resuscitation and serious complications includ-Editor: Helen Gharaei.
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1ageal intubation.[2] During cardiopulmonary resuscitation
(CPR), a pause of chest compression for placement of airway
devices should be brief to preserve tissue perfusion.[3] To
minimize interruptions of chest compression and catastrophic
events from intubation efforts, the use of a supraglottic airway
has been considered as an alternative to ETI due to its technical
ease and reduction of invasiveness.[1,4,5]
A variety of supraglottic airways have been introduced in the
ﬁeld of anesthesia and emergency situations. Compared to most
supraglottic airways with an inﬂatable cuff, the i-gel (Intersur-
gical Ltd.; Workingham, UK) has a gel-like cuff composed of
thermoplastic elastomer that does not require inﬂation.[6,7] If
successful insertion could be established in shorter insertion time
by omitting cuff inﬂation, the i-gel might be a more valid device in
emergency settings requiring prompt airway management.
Several previous studies supported this hypothesis.[8,9] However,
meta-analyses in the ﬁeld of anesthesia did not show consistent
results with regard to the insertion time of the i-gel.[6,7,10]
Simulation with manikins has been performed widely for
education and research related to airway management.[11,12]
Currently, there have been several comparative studies using
manikins in order to identify the optimal supraglottic airway for
various groups of healthcare providers under emergency
situations.[11,13,14] This systematic review and meta-analysis of
previous adult manikin studies for inexperienced personnel was
performed to compare the i-gel with other supraglottic airways.
An et al. Medicine (2017) 96:1 Medicine2. Methods
Our systematic review and meta-analysis was performed
according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses recommendations.[15] The protocol
for this study was registered with PROSPERO (registration
number: CRD42015024290). Ethics committee is not applicable
in this meta-analysis.
2.1. Data sources and search strategy
We included prospective randomized controlled trials (RCTs)
published before June 2015, including those with a crossover
design, that utilized adult-sized manikins to compare the i-gel
with any other type of supraglottic airway. Two authors (JA and
M-SK) independently performed database searches in PubMed,
the Cochrane Library, and EMBASE for eligible simulation trials
using the following search terms: “i-gel,” “igel,” “simulation,”
“manikin,” “manikins,” “mannequin,” and “mannequins.”
Language restrictions were not imposed in our searches. Studies
involving anesthesiologists were excluded from our reviews.
Disagreements over the inclusion or exclusion of studies were
resolved by the ﬁnal opinion of a third author (JSL). References
cited in the included articles were also investigated to discover
potentially eligible trials.
2.2. Data extraction
From the included trials, 2 authors (SBN and HML) independently
extracted the following data: name of the ﬁrst author, year of
publication, journal name, study design, participant characteristics
and number, presence of concurrent chest compression or difﬁcult
situations, and outcomes including insertion time and insertion
success rate. The primary outcomes of this review were device
insertion time and the ﬁrst-attempt success rate of insertion at the
initial assessment in difﬁcult situations. Additional outcomes such
as outcomes obtained at the second assessment or under difﬁcult
circumstances, the overall insertion success rate, and device
preference were included as secondary outcomes. The ﬁrst-attempt
or overall success rate was determined in accordance with the
deﬁnitions of insertion failure (e.g., time limitations and numbers of
insertion attempts) described in each study. When the values were
presented as median and total range, or an interquartile range of
values, themeanvaluewas estimated fromthedevised formulausing
the values of the median and the high and low ends of the range for
less than 25 samples, and themedian value itself was regarded as the
mean value for more than 25 samples. The standard deviation was
estimated from the devised formula using the values of the median
and high and low ends of the range for less than 15 samples,
the values of the range/4 for 15 to 70 samples, and the values of the
range/6 formore than 70 samples.When only an interquartile range
was provided from the selected articles, the standard deviation was
calculated using the interquartile range/1.35.[16,17]
2.3. Risk of bias assessment
Two authors (JA and JSL) evaluated the risks of bias in the
selected articles according to the Cochrane Collaboration’s tool
consisting of selection, performance, detection, attrition, report-
ing, and other sources of bias.[18] The bias was graded as “low
risk,” “high risk,” or “unclear.”
2.4. Statistical analysis
All analyses were conducted with Comprehensive Meta-Analysis
software (version 2.0, Biostat; Englewood, NJ) and R statistical2software (version 3.2.3; R Foundation for Statistical Computing,
Vienna, Austria, https://www.r-project.org), and all statistical
results are presented with 95% conﬁdence intervals (CIs). In
continuous variables such as insertion time, we calculated mean
difference (MD) at the individual study level and the pooled MD
using the inverse variance method in a ﬁxed-effect model or the
DerSimonian–Laird (D–L) method in a random-effects model. In
dichotomous variables, we calculated the relative risk (RR) at the
individual study level and the pooled RR using the Mantel–-
Haenszel (M–H) method in a ﬁxed-effect model or the D–L
method in a random-effects model. After discussion with a
medical statistician, the correlation coefﬁcient between devices
for meta-analysis of crossover comparisons was estimated as
0.5.[19] In addition, we chose the smaller value when the sample
sizes of 2 device groups under crossover trials were different. The
Q test and chi-squared test were performed to assess heterogene-
ity. Substantial heterogeneity of the effect sizes was deﬁned
as an I2 value of more than 50% or a P value of <0.10 on the
chi-squared test, for which we applied a random-effect model
instead of a ﬁxed-effect model. When applying the random-effect
model in data sets containing 3 or more individual studies, the
goodness-of-ﬁt test based on the Shapiro–Wilk test was
performed to check the adequacy of the random-effect model.
A P value of <0.05 suggested that the use of a random-effect
model would not be appropriate.[20]
Visual assessments of funnel plots and Egger linear regression
tests were conducted to conﬁrm the possibility of publication
bias. Asymmetry in funnel plots and a P value of <0.10 on Egger
test suggested the presence of publication bias.
3. Results
3.1. Eligible studies and study characteristics
We performed electronic database searches and included 14 full-
text articles, as shown in Fig. 1.[1,4,11,13,14,21–29] All studies were
randomized crossover trials except 1 with parallel design.[21] The
included articles contained several comparisons between the i-gel
and other supraglottic airways as follows: 4 comparisons with
the LMA Classic (LMA North America, Inc., San Diego,
USA),[11,22,25,29] 5 with the LMA Fastrach (Laryngeal Mask,
Prodol Meditec, Spain),[13,14,24,27,28] 3 with the LMA Proseal
(LMA North America, Inc., San Diego, USA),[1,14,23] 3 with the
LMA Supreme,[13,23,24] 5 with the LMA Unique (LMA North
America, Inc., San Diego, USA),[1,4,14,23,24] 7 with the laryngeal
tube (King-LT-D, VBM, Sulz, Germany),[1,4,13,14,21,22,24] 5 with
the Combitube (Covidien, Mansﬁeld, MA, USA),[1,4,13,14,24] 4
with the EasyTube (Teleﬂexmedical Ruesch, Research Triangle
Park, NC, USA),[1,4,13,24] 1 with the SoftSeal (Smiths Medical
International Ltd, Ashford, Kent, UK),[26] 1 with the AuraOnce
(Ambu, Ballerup, Denmark),[26] 1 with the aura-i,[27] and 1
with the air-Q (Cookgas LLC, Mercury Medical, USA).[27]
Characteristics of the included articles are summarized in Table 1.
In 4 studies, the evaluation was repeated after 3 or
12 months.[1,13,23,24] Four studies included insertions of devices
under difﬁcult circumstances, such as while wearing protective
equipment and applying a neck collar and pathologic airway
conditions.[14,24,25,29] In this meta-analysis, insertion variables
investigated at the second assessment or under difﬁcult circum-
stances were analyzed additionally. Robak et al’s[24] study
assessed device insertion under simulated physiologic and
pathologic airway conditions at the initial and second assess-
ments. However, the insertion success rate under physiologic
conditions was only included in this analysis as its exact values
Figure 1. Flow diagram showing data searches and article selection.
An et al. Medicine (2017) 96:1 www.md-journal.cominvestigated under pathologic airway conditions were not stated
at both of the assessments. In addition, the insertion times
measured under pathologic airway conditions at each assessment
time were regarded and analyzed as those from a single study.
Ongoing chest compression during device insertion was applied
in 4 studies.[4,26,27,29] However, Ruetzler et al’s[4] study allowed
transient interruption of chest compression during airway
management as required by participants. In Adelborg et al’s[26]
study, we could not conﬁrm outcomes during concurrent chest
compression. Komasawa et al’s[27] study assessed the insertion of
devices under both situations with and without chest compres-
sion. When conducting analyses using this study, the outcomes
obtained from each situation were regarded and analyzed as
those from a single study.
Considering the aim of this meta-analysis and the level of
participants’ experience in other trials, we only used the results of
novice physicians in the trial by Stroumpoulis et al.[11] Castle
et al’s[14] 2011 study provided insertion success rates according to
certain time periods, and a successful insertion rate within 30
seconds was regarded as the ﬁrst-attempt success rate. The
insertion success rate from Komasawa et al’s[27] study was also
regarded as a ﬁrst-attempt success rate as the success or failure of
insertion within 30 seconds was investigated. Leventis et al’s[28]
study presented insertion times and success rates at each attempt
of device placement, and we selected the results at the ﬁrst-
attempt insertion for this analysis.3.2. Risk of bias assessment
Risks of bias are presented in Table 2. In all enrolled studies,
performance and detection bias regarding the blinding of3participants and assessors was graded as high risk. Conﬂicts of
interest were reported in 6 trials,[1,4,13,22–24] and regarded as
other bias.[30]3.3. Meta-analysis of primary outcome measures
The insertion times at the initial assessment without difﬁcult
circumstances were obtained from all of the included studies. The
forest plots regarding regarding pooled analyses of the i-gel and
each other supraglottic airway with 2 or more comparisons from
the included studies were provided in Fig. 2. The i-gel had a
signiﬁcantly shorter insertion time than the LMA Classic, LMA
Fastrach, LMA Proseal, LMA Unique, laryngeal tube, Combi-
tube, and EasyTube. However, a faster insertion time of the i-gel
was not observed in comparisons with the LMA Supreme, aura-i,
and air-Q. In SoftSeal and AuraOnce with only 1 comparison, the
insertion time of the i-gel was signiﬁcantly faster than both of the
devices (MD 19.60, 95% CI 21.53 to 17.67; MD 19.50,
95% CI 21.80 to 17.20, respectively). Overall analysis of the
i-gel and all other supraglottic devices showed that the i-gel
reduced mean (95% CI) insertion time by 8.09 (9.70, 6.47)
seconds compared to other supraglottic airways (P<0.001), but
there was substantial heterogeneity (I2=99%).
Data regarding the success rates of the ﬁrst-attempt insertion
at the initial assessment without difﬁcult circumstances were
obtained from 11 studies.[4,11,14,21–28] In the 2 included
studies,[22,24] all of the device insertions were successfully
established at the ﬁrst attempt. The meta-analysis results of
the ﬁrst-attempt insertion success rate from the remaining
9 studies are described in Table 3. The i-gel had a signiﬁcantly
lower success rate than the LMA Supreme and EasyTube.
Table 1
Characteristics of the included RCTs.
Reference Participants
∗
Devices/manikin Intervention Collected outcomes COI
Wiese et al[21] 200 paramedics (100
per group)
i-gel, laryngeal tube/Resusci
Anne Advanced Skilltrainer
with an Airway Trainer head
No crossover design, temporary
interruption of chest
compression during insertion,
no difﬁcult situations, and
single assessment
Insertion time and ﬁrst-attempt
success rate
No
Castle et al[22] 36 paramedic students i-gel, Classic, and laryngeal tube/
a Laerdal advanced airway
trainer manikin
Crossover design, no chest
compression, no difﬁcult
situations, and single
assessment
Insertion time, ﬁrst-attempt
success rate, and preference
(would elect to carry)
Yes
Castle et al[14] 58 paramedic students i-gel, Fastrach, Proseal, Unique,
laryngeal tube, and
Combitube/the Laerdal
Advanced Airway Trainer
Crossover design, no chest
compression, difﬁcult
situations (wearing chemical,
biological, radiation, or
nuclear-personal protective
equipment), and single
assessment
Insertion time, ﬁrst-attempt
success rate (insertion within
30s), overall success rate
(insertion within 120s),
preference, and ease of
insertion
No
Fischer et al[23] 267 medical students i-gel, Proseal, Supreme, and
Unique/an Ambu Cardiac Care
Trainer
Crossover design, no chest
compression, no difﬁcult
situations, and double
assessments (initial and 12mo
later)
Insertion time, ﬁrst-attempt
success rate, overall success
rate, gastric insufﬂation, and
ease of use
Yes
Ruetzler et al[1] 40 emergency medical
technicians
i-gel, Unique, laryngeal tube,
Combitube, EasyTube, and
ETI/a Resusci Anne Advanced
Simulator
Crossover design, ongoing chest
compression (transient
interruption of chest
compression when participants
were required to stop
compression), no difﬁcult
situation, and single
assessment
Insertion time, ﬁrst-attempt
success rate, overall success
rate, and hands-off time
Yes
Ruetzler et al[4] 41 paramedics i-gel, Proseal, Unique, laryngeal
tube, Combitube, EasyTube,
and ETI/advanced patient
simulator SimMan
Crossover design, no chest
compression, no difﬁcult
situations, and double
assessments (initial, 3mo
later)
Insertion time and overall
success rate
Yes
Robak et al[24] 45 medical students i-gel, Fastrach, Supreme, Unique,
laryngeal tube, Combitube,
and EasyTube/Laerdal SimMan
3G
Crossover design, no chest
compression, difﬁcult
situations (trismus, limited
mobility of cervical spine,
tongue edema, and
combination of 2 conditions),
and double assessments
(initial, 3mo later)
Insertion time and ﬁrst attempt
success rate
Yes
Stroumpoulis et al[11],
∗
66 novice physicians i-gel and Classic/an adult
Resusci Anne
Crossover design, no chest
compression, no difﬁcult
situations, and single
assessment
Insertion time and ﬁrst-attempt
success rate
No
Goliasch et al[13] 50 medical students i-gel, Fastrach, Supreme,
laryngeal tube, Combitube,
EasyTube, and ETI/an
advanced patient simulator
SimMan
Crossover design, no chest
compression, no difﬁcult
situations, and double
assessments (initial, 3mo
later)
Insertion time and overall
success rate
Yes
Kwak et al[25] 102 medical and
paramedic students
and nurses
i-gel and Classic/an Airway
Management Trainer
Crossover design, no chest
compression, difﬁcult
situations (the application of a
neck collar in a manikin), and
single assessment
Insertion time, ﬁrst-attempt
success rate, self-assessment
questionnaire, and preference
No
Adelborg et al[26] 40 lifeguards i-gel, SoftSeal, and AuraOnce/
Ambu Cardiac Care Trai-ner
System
Crossover design, device
insertion with or without
ongoing chest compression,
no difﬁcult situations, and
single assessment
Insertion time, ﬁrst-attempt
success rate, and preference
No
Komasawa et al[27] 20 novice physicians i-gel, Fastrach, aura-i, and air-Q/
The AirMan
Crossover design, device
insertion with or without
ongoing chest compression,
Insertion time, ﬁrst-attempt
success rate, and number of
No
An et al. Medicine (2017) 96:1 Medicine
4
Reference Participants
∗
Devices/manikin Intervention Collected outcomes COI
no difﬁcult situations, and
single assessment
successful blind intubations
during chest compression
Leventis et al[28] 72 paramedics i-gel, Fastrach, ETI/Resusci Anne Crossover design, no chest
compression, no difﬁcult
situations, and single
assessment
Insertion time at ﬁrst-attempt,
ﬁrst-attempt success rate, and
overall success rate
No
Lee et al[29] 38 EMT students i-gel, LMA Classic, ETI/the
Resusci Anne simulator
Crossover design, ongoing chest
compression, difﬁcult
situations (tongue inﬂation),
and single assessment
Insertion time, overall success
rate, and ease of insertion
No
∗
We only used the results of novice physicians in the trial by Stroumpoulis et al. In other studies, all participants were equally inexperienced in all supraglottic airway devices. COI, conﬂict of interest; Classic, LMA
Classic; Fastrach, LMA Fastrach; Proseal, LMA Proseal; Supreme, LMA Supreme; Unique, LMA Unique; EMT, Emergency Medical Technology.
An et al. Medicine (2017) 96:1 www.md-journal.com3.4. Meta-analysis of secondary outcome measures
Data regarding insertion times obtained at the second assessment
without difﬁcult circumstances were collected from 4 stud-
ies.[1,13,23,24] Signiﬁcantly faster insertion of the i-gel was
conﬁrmed only in comparisons with the laryngeal tube and
Combitube (Table 4).
Four studies reported the insertion times obtainedunder difﬁcult
circumstances at the initial or second assessment.[14,24,25,29] Meta-
analysis outcomes are demonstrated in Table 5. The i-gel was
placed more quickly than the LMA Classic and LMA Proseal,
whereas signiﬁcantly slower insertion of the i-gel was observed in
comparisons with the EasyTube and LMA Supreme.
The ﬁrst-attempt insertion success rates at the second
assessment without difﬁcult circumstances were provided in 2
of the included studies.[23,24] In 1 study,[24] all devices were
placed successfully at the ﬁrst attempt. In the other study,[23] the
success rate of the i-gel was the higher than those of the LMA
Proseal and LMAUnique (RR 1.32, 95%CI 1.20–1.45; RR 1.33,
95% CI 1.21–1.47, respectively), whereas it was the lower than
that of the LMA Supreme (RR 0.94, 95% CI 0.89–1.00).
The ﬁrst-attempt insertion success rates under difﬁcult
circumstances were reported in 2 of the included studies.[14,25]
One study reported a superior success rate of the i-gel when
compared with those of the LMA Fastrach, LMA Proseal, LMA
Unique, laryngeal tube, and Combitube.[14] In the other study,Table 2
Risk of bias assessment.
Reference
Random
sequence
generation
Allocation
concealment
Blinding o
participan
and personn
Wiese et al[21] Unclear Unclear High risk
Castle et al[22] Unclear Unclear High risk
Castle et al[14] Unclear Unclear High risk
Fischer et al[23] Low risk Unclear High risk
Ruetzler et al[1] Low risk Unclear High risk
Ruetzler et al[4] Low risk Unclear High risk
Robak et al[24] Low risk Low risk High risk
Stroumpoulis et al[11] Low risk Low risk High risk
Goliasch et al[13] Low risk Unclear High risk
Kwak et al[25] Unclear Low risk High risk
Adelborg et al[26] Unclear Unclear High risk
Komasawa et al[27] Unclear Unclear High risk
Leventis et al[28] Low risk Low risk High risk
Lee et al[29] High risk High risk High risk
5there was no signiﬁcant difference in the success rate between the
i-gel and LMA Classic (RR 1.02, 95% CI 0.99–1.05).[25]
Overall insertion success rates were collected from 7
studies.[1,4,13,14,23,28,29] There were no signiﬁcant differences in
the overall success rate between the i-gel and other devices, except
the LMA Proseal[1,23] and LMA Unique[23] at the second
assessment without difﬁcult circumstances (RR 1.13, 95% CI
1.00–1.28; RR 1.11, 95% CI 1.06–1.16, respectively).
3.5. Ancillary results from systemic review
Participants were asked about device preference in 4 stud-
ies,[14,22,25,26] and the i-gel was the most preferred device in all
surveys. Ease or difﬁculty of device use was investigated in 3
studies.[14,23,29] In Fisher study, the i-gel and LMA Supreme
together were graded as easier to use compared to the LMA
Unique and LMA Proseal.[23] In the remaining 2 studies, the i-gel
received better scores than other devices.[14,29] One study
evaluated gastric insufﬂation after insertion,[23] and the i-gel
had the lowest rate (0%) at initial testing and a signiﬁcantly
increased rate (4%) at second testing after 12 months. From this
study, the LMA Supreme showed the best results regarding
gastric insufﬂation (1% at initial testing and 2% at second
testing). Success rates of blind intubation with 4 supraglottic
airways under ongoing chest compression were evaluated in 1
study.[27] The highest success rate was observed in the air-Q (15f
t
el
Blinding of
outcome
assessment
Incomplete
outcome
data
Selective
reporting
Other
bias
High risk Low risk Unclear Low risk
High risk Low risk Low risk High risk
High risk Low risk Low risk Low risk
High risk Low risk Low risk High risk
High risk Low risk Low risk High risk
High risk Low risk Low risk High risk
High risk Low risk Low risk High risk
High risk Low risk Low risk Low risk
High risk Low risk Low risk High risk
High risk Low risk Low risk Low risk
High risk Low risk Unclear Low risk
High risk Low risk Low risk Low risk
High risk Low risk Low risk Low risk
High risk Low risk Low risk Unclear
Figure 2. Forest plots denoting comparisons of insertion time at the initial assessment without difﬁcult circumstances between the i-gel and other supraglottic
airways. D–L = DerSimonian–Laird. †analysis with smaller sample size; ‡insertion during chest compression.
An et al. Medicine (2017) 96:1 Medicineof 19) compared to the aura-i (14 of 19), i-gel (12 of 16), and
LMA Fastrach (10 of 18).4. Discussion
Our systematic review and meta-analysis revealed that the
insertion time of the i-gel was signiﬁcantly shorter than those of
the LMA Classic, LMA Fastrach, LMA Proseal, LMA Unique,6laryngeal tube, Combitube, and EasyTube in the initial
assessment without difﬁcult circumstances. However, the
superiority of the ﬁrst attempt and overall success rates of
insertion in the i-gel was not apparent.
Speed of insertion is the most important prerequisite when
selecting a supraglottic airway for securing airway patency
during CPR, as recent resuscitation guidelines emphasize that
chest compressions should be interrupted brieﬂy for placement of
[3,4,31]
Figure 2. Conitued.
An et al. Medicine (2017) 96:1 www.md-journal.comairway devices. The i-gel can be considered as a reasonable
candidate for meeting this requirement due to its noninﬂatable
cuff and design for easy insertion.[32] Meta-analyses to secure
evidence for the superiority of the i-gel have been carried out
primarily in the ﬁeld of anesthesia. A meta-analysis of the adult-
sized i-gel under general anesthesia demonstrated that the i-gel
had a shorter insertion time than other devices.[7] However,
heterogeneity in the pooled results of insertion time was
substantial, and faster insertion times of the i-gel were not7observed in subgroup analyses of second-generation devices
including the LMA Proseal and LMA Supreme. In a meta-
analysis of pediatric patients under general anesthesia, a pooled
analysis did not show a signiﬁcant difference in insertion time
between the i-gel and different types of LMAdevices, and the i-gel
had an inferior result in a subgroup analysis with the LMA
Supreme and AuraOnce (MD 1.69 seconds, 95% CI 0.25–3.13,
P=0.02, I2=27%).[6] Chen et al[10] performed a meta-analysis
using studies comparing the i-gel and LMA Supreme, and no
Table 3
Meta-analysis of the ﬁrst-attempt insertion success rate at the initial assessment without difﬁcult circumstances between the i-gel and
other supraglottic airways.
Insertion success rate
Comparator i-gel Comparator Risk ratio (95% CI) P I2, % Model GoF test P in Egger test
LMA Classic[11,25] 162/168 132/168 1.38 (0.73, 2.61) 0.323 95.6 D–L random  
LMA Fastrach[14,27,28],
∗
165/170 140/170 1.10 (0.89, 1.37) 0.379 86.2 D–L random 0.140 0.754
LMA Proseal[14,23] 320/325 282/314 1.14 (0.97, 1.34) 0.107 81.7 D–L random  
LMA Supreme[23] 262/267 267/267 0.98 (0.96, 1.00) 0.041    
LMA Unique[4,14,23] 339/365 309/359 1.16 (0.77, 1.73) 0.483 91.5 D–L random 0.273 0.649
Laryngeal tube[4,14,21] 173/198 181/198 0.98 (0.85, 1.13) 0.750 81.3 D–L random 0.09 0.733
Combitube[4,14] 77/98 56/97 1.19 (0.26, 5.51) 0.822 97.6 D–L random  
EasyTube[4] 19/40 30/40 0.63 (0.44, 0.92) 0.016    
SoftSeal[26] 39/40 40/40 0.98 (0.91, 1.04) 0.475    
AuraOnce[26] 39/40 38/40 1.03 (0.94, 1.12) 0.557    
Aura-i[27],
∗
34/40 38/40 0.89 (0.77, 1.04) 0.190 0 M–H ﬁxed  
Air-Q[27],
∗
34/40 38/40 0.89 (0.77, 1.04) 0.190 0 M–H ﬁxed  
CI = conﬁdence interval, GoF = goodness-of-ﬁt, D–L = DerSimonian–Laird.
∗
Komasawa study provided outcomes under both situations with and without chest compression; thus, the outcomes from each situation were regarded and analyzed as those from a single study.
An et al. Medicine (2017) 96:1 Medicinedifferences in device placement time were found in a pooled
analysis of the 2 devices.
From our systemic review, the i-gel was inserted more rapidly
than other devices in most of the included papers. However,
several studies reported contradictory results that may have been
responsible for the heterogeneity of the meta-analyses out-
comes.[24,27] Robak et al[24] reported that the insertion time of the
i-gel was greater in most of the comparisons, while in Komasawa
et al’s[27] study, the time required for i-gel insertion without chest
compression was shorter than those of the LMA Fastrach, aura-i,
and air-Q. When applying chest compression, the i-gel insertion
time was lengthened signiﬁcantly, resulting in the i-gel showing
the longest insertion time under chest compression. The authors
commented that these results might have been due to the
anatomically curved shaft that is present on the other 3
supraglottic airways yet absent from the i-gel.[27] Under
anesthesia, the LMA Supreme also showed similar insertion
times when compared to the i-gel.[6,7,10] From our meta-analyses,
a faster insertion time of the i-gel was not observed in
comparisons with the LMA Supreme. The LMA Supreme also
has a semirigid and anatomically curved airway tube.[10] Thus,
the morphologically improved airway tube of supraglottic
airways, such as a noninﬂatable cuff, may also reduce the
insertion time.Table 4
Meta-analysis of insertion time at the second assessment without
airways.
Total number of participants
Comparator i-gel Comparator MD (95% CI)
LMA Fastrach[13,24] 95 95 0.91 (6.95, 5
LMA Proseal[1,23] 307 295
∗ 19.14 (45.26,
LMA Supreme[13,23,24] 361 360
∗ 2.39 (6.40, 1
LMA Unique[1,23,24] 352 345
∗ 3.01 (8.28, 2
Laryngeal tube[1,13,24] 136 136 3.48 (6.82, 
Combitube[1,13,24] 136 136 8.64 (16.37,
EasyTube[1,13,24] 136 136 7.20 (15.26,
CI = conﬁdence interval, GoF = goodness-of-ﬁt, D–L = DerSimonian–Laird, MD = mean difference.
∗
Analysis with smaller sample size.
8The success rate of ﬁrst-attempt insertions is also a signiﬁcant
selection criterion for choosing the supraglottic airway in an
emergency setting.[33] From the abovementioned meta-analyses
in the anesthesia area, the insertion success rate at the ﬁrst
attempt for the i-gel was similar to those of other devices.[6,7,10]
Maitra et al[17] also evaluated the i-gel in children via meta-
analysis, and no difference was observed in the ﬁrst-insertion
success rate. In the present meta-analysis, the superiority of the
insertion success rate at the ﬁrst attempt for the i-gel was not
apparent. In addition, the i-gel had a lower success rate when
compared with the LMA Supreme (RR 0.98, 95% CI 0.96–1.00,
P=0.041), although there was only 1 comparison between the 2
devices.[23] Ragazzi et al[34] reported a better ﬁrst-attempt success
rate, a higher sealing pressure, and fewer failures with the LMA
Supreme than with the i-gel when devices were inserted into
patients under general anesthesia by inexperienced operators.
Hence, additional studies regarding the feasibility of supraglottic
airways with an anatomically curved shaft such as the LMA
Supreme are needed in order to select themost adequate airway in
an emergency setting.
Our meta-analysis had several limitations that must be
considered when interpreting the results. First, there was
considerable heterogeneity in most of the meta-analyses.
Essentially, the heterogeneity could have originated fromdifﬁcult circumstances between the i-gel and other supraglottic
, s P I2, % Model GoF test P in Egger test
.13) 0.768 99.1 D–L random  
6.97) 0.151 98.6 D–L random  
.62) 0.243 99.2 D–L random 0.261 0.216
.27) 0.264 99.2 D–L random 0.445 0.984
0.13) 0.042 97.2 D–L random 0.394 0.297
0.90) 0.029 99.4 D–L random 0.719 0.627
0.85) 0.080 99.6 D–L random 0.850 0.603
Table 5
Meta-analysis of insertion time under difﬁcult circumstances between the i-gel and other supraglottic airways.
Total number of participants
Comparator i-gel Comparator MD (95% CI), s P I2 (%) Model GoF test P in Egger test
LMA Classic[25,29] 140 140 12.74 (24.6, 0.89) 0.035 99.4 D–L random  
LMA Fastrach[14,24],
∗
148 148 12.27 (30.1, 5.56) 0.178 98.8 D–L random 0.150 0.321
LMA Proseal[14] 58 58 25.00 (28.57, 21.43) <0.001    
LMA Supreme[24],
∗
90 90 5.43 (3.78, 7.08) <0.001 0 IV ﬁxed  
LMA Unique[14,24],
∗
148 148 8.08 (24.38, 8.22) 0.331 99.0 D–L random 0.019 0.278
Laryngeal tube[14,24],
∗
148 148 4.84 (17.54, 7.87) 0.455 98.7 D–L random 0.291 0.462
Combitube[14,24],
∗
148 148 11.99 (33.57, 9.59) 0.276 99.4 D–L random 0.033 0.170
EasyTube[24],
∗
90 90 5.35 (3.71, 7.00) <0.001 37.7 IV ﬁxed  
CI = conﬁdence interval, GoF = Goodness-of-Fit, D–L = DerSimonian–Laird, IV = inverse variance, MD = mean difference.
∗
Robak et al’s study provided insertion times under difﬁcult circumstances at the initial and second assessments; thus, the outcomes from each assessment were regarded and analyzed as those from a single
study.
An et al. Medicine (2017) 96:1 www.md-journal.commethodological differences among the included studies (which
had parallel or crossover designs), the deﬁnition of insertion time,
and the presence of chest compression or difﬁcult situations. In
particular, the use of several types of manikins could also affect
the insertion performance of each supraglottic airway.[35] In
addition, the study participants of various occupations have
different experiences each other for supraglottic airway. These
differences in degree of education or experience related to
supraglottic airways could have been the most likely cause of
these heterogeneous results, given that various groups including
paramedics, students, nurses, and physicians inserted the devices
in each study. The more variable MDs of insertion times in the
simulation studies included in this meta-analysis (–31 to 5.4
seconds) might support this assumption, particularly when
compared to the studies on insertion under general anesthesia
(–11 to 3 seconds).[6,7,10] Second, information on sealing function
from the included simulation trials was not present except in 1
trial assessing gastric insufﬂation.[23] Adequate sealing function
in supraglottic airways, which is mainly evaluated by measuring
the oropharyngeal leak pressure is important for maintaining
ventilation and protecting the airway from secretions.[17] Given
that the oropharyngeal leak pressure of the i-gel assessed under
anesthesia was similar or superior to those of other devices,[7,17] it
was expected that the sealing function of the i-gel was also
acceptable under emergency situations. Third, an airway model
using amanikin is not a clinical model; thus, results frommanikin
studies may not be valid. However, simulation with manikins
allows for stricter control of possible confounding factors when
conducting a study.[11] In addition, a prospective study that
compares and validates airway devices in an emergency setting
may not be easy to perform using human subjects. Fourth, none
of the included studies were free from performance or detection
bias. Blinding of participants and assessors was impossible due to
the methodology used in simulation studies with supraglottic
airways.[17] Lastly, as we were unable to calculate correlation
coefﬁcients for our enrolled crossover studies, a ﬁxed cutoff value
was used for our meta-analysis.
In conclusion, current evidence based on simulation trials
implied that inexperienced volunteers placed the i-gel into the
manikins more rapidly than other supraglottic airways, except
the LMA Supreme, aura-i, and air-Q. Within the limitations of
the simulation setting using manikins, these results suggest that
the i-gel is more beneﬁcial for inexperienced medical personnel
under sudden emergency situations. However, the quicker
insertion time is clinically not relevant. The unapparent9advantage regarding the insertion success rate and the substantial
heterogeneity in our meta-analysis indicated that additional
evidence is necessary to conﬁrm these advantages of the i-gel in an
emergency setting.References
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